Data on 984 stable coronary heart disease patients showed those with the highest high-sensitivity cardiac troponin-T levels were more than five times as likely than those with the lowest levels to suffer myocardial infarction, hospitalization for heart failure or cardiovascular death. "These findings suggest that hs-cTnT levels quantify an element of risk that is not captured by existing measures of cardiovascular disease severity," the authors wrote in JAMA: Internal Medicine.
Test could help predict secondary cardiovascular risk, study finds
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan